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Abstract
Studies designed to assess persistent postoperative pain (PPP) incidence after hepatectomies are lacking. Our aim was to assess
PPP incidence 6 months after hepatectomies with intravenous (IV) or epidural (EPI) analgesia containing ketamine.
Prospective observational comparative study between 2 cohorts of patients submitted to hepatectomy. Patients received 1 of 2
analgesic regimes containing ketamine: EPI group or IV group. Visual analog scale (VAS), Neuropathic Pain Symptom Inventory
(NPSI), Pain Catastrophizing Scale (PCS), and quantitative sensorial testing (QST: to determine area of hyperalgesia/allodynia) were
assessed preoperatively and postoperatively at 2h, 24h, 7 days, 1month, and 6months. VAS≥ 1 at 1 and 6months was considered
indicative of PPP and VAS > 3 was considered as not controlled pain. Side effects and complications were registered.
Forty-four patients were included: 23 in EPI group and 21 in IV group. Patients in IV group were older and had more comorbidities.
No patient presented VAS > 3 at 1 or 6 months. VAS ≥ 1 at 1 and 6 months was 36.4% and 22.7%, respectively. No differences in
VAS, NPSI, or PCS were found between groups. Allodynia/hyperalgesia area did not differ between groups and was infrequent and
slight. Pain pressure threshold in the wound vertical component was signiﬁcantly higher in EPI group after 7 days. IV group showed
more cognitive side effects.
Incidence of PPP at 6 months after open hepatectomies with EPI or IV analgesia containing ketamine was lower than previously
reported for other abdominal surgeries.
Ketamine inﬂuence on low PPP incidence and hyperalgesia cannot be discarded.
Abbreviations: EFV = electronic Von Frey, EPI = epidural, IV = intravenous, NMDAr = N Metil D Aspartate receptors, NPSI =
Neuropathic Pain Symptom Inventory, PCA = patient controlled analgesia, PCS = Pain Catastrophizing Scale, PONV =
postoperative nausea/vomiting, PPP= persistent postoperative pain, QST= quantitative sensorial testing, VAS= visual analog scale,
VFM = Von Frey monoﬁlaments.
Keywords: hepatectomy, ketamine, neuropathic pain, persistent postoperative pain, quantitative sensorial testing
1. Introduction generates secondary hyperalgesia that could intervene not only inIncidence of persistent postoperative pain (PPP) after abdominal
surgery has been reported between 0% and 34%.[1,2] Studies
speciﬁcally designed to evaluate the incidence of PPP after open
hepatectomies have not been published to date. In 2 studies on
quality of life after hepatic surgery, the incidence of PPP was
reported between 9% and 50%.[3–5] The main component of PPP
is neuropathic and the central sensitization after nervous injuryEditor: Maria Kapritsou.
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1the intensity of the perception of immediate postsurgical pain but
also in chroniﬁcation of pain after healing of the wound.[6–8]
Nervous injury and intensity of acute postoperative pain are the
most constant predisposing factors after abdominal surgery.[9]
Relation of PPP with uncontrolled postoperative pain makes
postsurgical analgesia the most accessible way to prevent PPP.
Secondary hyperalgesia has been related to PPP.[5] In
conventional hepatic resection, the predominant surgical incision
has a vertical supraumbilical medial component and a horizontal
subcostal component. Thoracic epidural (EPI) analgesia has been
considered the most effective analgesic technique for hepatic
resection surgery in multiple series,[10–13] although the frequent
pre- and postsurgical coagulation alterations in these patients
make its indication controversial.[14,15] The doses of
opioids[16,17] and nonsteroidal anti-inﬂammatory drugs[18] for
intravenous (IV) analgesia are limited in patients with hepatic
disease, reason for which low-dose ketamine is frequently
associated.[19]
N Metil D Aspartate receptors (NMDAr) have a key role in
central sensitization causing PPP, which is manifested as
secondary hyperalgesia. Ketamine is one of the few clinically
available NMDAr antagonists and it is widely used in a
complimentary way for postsurgical analgesia.[19–23] There is
clear evidence that ketamine decreases intensity of postsurgical
acute pain,[19,21,23] but results regarding its effect in PPP
prevention are inconsistent, although it is proven to reduce the
[24–26]
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higher concentrations closer to the NMDAr activation areas
in the spinal cord by its EPI administration is being
studied.[24,27,28]
Great variability about PPP incidence and its response to
treatments may be attributed to subjectivity in the evaluation of
pain, lack of long-term follow-up, and heterogeneity in applied
analgesic protocols. Our research group has designed a simpliﬁed
protocol for PPP assessment that combines subjective scales with
quantitative sensory tests (QST), to detect intensity, extension,
and evolution of secondary hyperalgesia.[24,29]
The aim of this study was to determine PPP incidence during
the ﬁrst 6 months after open hepatectomies and its relationship
with the hyperalgesia area andwith the analgesic techniques most
frequently used in our institution.2. Patients and method
2.1. Patients
The study was approved by the Research Ethics Board of our
institution as an observational comparative study between 2
cohorts registered as HCB/2016/0690.
Patients over 18 years of age scheduled for conventional
hepatic resection surgery according to Brisbane terminology[30] in
our institution during 18 months were considered for inclusion.
Major resection was deﬁned as the 1 developed on 3 or more
adjacent segments. Inclusion was conﬁrmed the day before
surgery after obtaining written consent.
Exclusion criteria were patient refusal, previous chronic pain
or chronic analgesic treatment, history of drug addiction or
neurological/psychiatric disorder, cirrhosis, contraindication to
any drug going to be used, emergency surgery, previous upper
abdominal surgery, anticipation of nonresectable disease because
of extension, and prevision of nonimmediate extubation after
surgery.
The day before surgery, patients were instructed about how to
refer pain using the visual analog scale (VAS 0–10) and the use of
an electronic patient controlled analgesia (PCA) pump. Neuro-
pathic Pain Symptoms Inventory (NPSI),[24,31] Pain Catastroph-
izing Scale (PCS),[24,32] and QST (Von Frey monoﬁlaments
[VFM], electronic Von Frey [EVF], and electric toothbrush) were
explained and applied as baseline measurements. Patients were
instructed to report a “painful” sensation with QST when a
“change in perceived stimulation was disturbing enough to make
him/her wish to stop it.”Table 1
Analgesic regimen administered in both groups.
EPI gro
Bolus before surgical incision Epidural route: ketamine 0.5mgkg
lidocaine 1% 6 mL
Infusion during surgery None
Bolus 20 min before end of surgery IV route: morphine
Patient controlled analgesia started 20min before
the end of surgery until 5th postoperative day
Epidural route (5 mL h1): ketami
15 mg mL1 + ropivacaine 0.1
Complementary analgesia since the end of
surgery until 5th postoperative day
IV route: acetaminophen 1 g every
subcutaneous if VAS > 3
Analgesic regimen from 5th postoperative day on IV route: acetaminophen 1 g every
subcutaneous if VAS > 3
EPI = epidural, IV = intravenous, VAS = visual analog scale.
2Patients were classiﬁed into 2 groups according to the type of
analgesia they received: EPI group or IV group. The decision on
which type of analgesia each patient would receive was made by
the responsible anesthesiologist (PT) based on general criteria of
contraindications for both techniques.
According to the criteria previously used by our group,[24,26]
values of VAS ≥ 1 at 1 and 6 months were considered indicative
of PPP and VAS > 3 was considered as not controlled pain. Any
positive change in QST with respect to the preoperative baseline
examination was considered as allodynia/hyperalgesia. Lack of
sensitivity with all the QST was considered as anesthesia.2.2. Anesthesia and surgical procedures
Sublingual diazepam 5 to 10mg was administered the night
before surgery and IV midazolam 0.025mgkg1 was given at the
arrival to the operating room. In the EPI group, an EPI catheter
was inserted at the vertebral interspace T7–8 before anesthesia
induction. Monitoring included electrocardiogram, pulse oxy-
metry, capnography, invasive arterial pressure, central venous
pressure, esophageal temperature, urine output, and bispectral
index. Induction of anesthesia consisted of fentanyl (2–3 mg
kg1), propofol (1mgkg1), and cisatracurium (0.15mgkg1).
Anesthesia was maintained with desﬂurane 4% to 6% in O2/air
60% (to keep BIS between 40 and 50) and cisatracurium 0.1mg
kg1h1. After induction the analgesic technique was set up as
foreseen, EPI group or IV group. Patients were extubated in the
operating room when awake, following residual muscle block
reversal with neostigmine. Patients remained monitored in the
postanesthetic care unit for 24h.2.3. Analgesia
Analgesic regimen for both groups is described in detail in
Table 1.
2.3.1. EPI group. Before surgical incision, an EPI bolus of
lidocaine + morphine was administered. Twenty minutes before
skin closure, patients received an IV bolus of morphine and the
EPI PCA pump was started and kept for 5 days. PCA pump was
programmed to administer 5 mLh1, with possibility of 2 boluses
of 3 mL in 1 h and lockout interval of 20 min.
2.3.2. IV group. Before surgical incision, an IV bolus of ketamine
was administered and an IV infusion of morphine was started.
Twenty minutes before skin closure, patients received an IV bolus
of morphine and the IV PCA pump was started and kept forup IV group
1 + morphine 4mg + IV route: ketamine 0.5mgkg1
IV route: morphine 0.025mgkg1 h1
0.05mgkg1
ne 1.5mg mL1+ morphine
5%
IV route (1mL h1): ketamine 7.5mg mL1 +
morphine 1mg mL1+ ketorolac 1.5mg
mL1
8h and methadone 4mg
8h and methadone 4mg
1
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with possibility of 3 boluses of 0.5 mL in 1 h and lockout interval
of 5 min.
In addition, both groups received IV acetaminophen 1g every
8h and subcutaneous methadone 4mg if VAS > 3. After PCA
stop (either EPI or IV) on day 5 postsurgery, acetaminophen and
methadone were continued.Figure 1. Von Frey monoﬁlaments and electronic Von Frey measurements.2.4. Outcome assessment
2.4.1. Subjective scales. VAS was evaluated the day before
surgery and postoperatively at 2h, 24h, 7 days, 1 month, and
6 months. Patients also completed NPSI,[31] which allows
identiﬁcation and qualiﬁcation of neuropathic symptoms
reﬂecting spontaneous or paroxysmal pain and evoked pain,
that was considered positive with scores higher than zero. PCS
was also ﬁlled,[32] which measures presence of distress reactions
to nociceptive stimulation. These 2 last tests were evaluated the
day before surgery and at 1 and 6months after surgery. NPSI was
also completed on day 7 after surgery.
2.4.2. Quantitative sensory testing. All tests were performed
the day before surgery (baseline) and at 7 days, 1 month, and
6 months after surgery by the same expert investigator in this
evaluation (BT). All mechanical measurements were carried out
around the surgical incision (horizontal and vertical component)
and at the middle third of the contralateral thigh as a control skin
zone.– Von Frey monoﬁlaments (VFM): Area of allodynia/hyper-
algesia for punctuate mechanical stimuli around the surgical
incision was tested using nylon monoﬁlaments (Bioseb,
Vitrolles, France) of constant length and increasing diameter
which exert escalating pressure proportional to their diameter.
In accordance with the method described by Stubhaug,[33,34]
consecutive stimulation was applied with 3 monoﬁlaments of
0.6, 2, and 10g. The day before surgery, QST were applied in
the area where the incision would be made and in the thigh.
After the surgery, VFMwere applied starting 10cm away from
the wound where no pain sensation was experienced, moving
toward the incision in different radial axis until the patient
reported a change in perception. In each axis, the ﬁrst point
where a “painful” or “sharper” sensation occurred was
marked and the distance to the wound was measured. If no
change in sensation occurred, the stimulation stopped at 0.5cm
from the incision. The area of allodynia/hyperalgesia was
determined as a rectangle whose long axis was the wound
length plus the distance of allodynia/hyperalgesia if present;
and the short axis the distance of allodynia/hyperalgesia above
and under the incision in the horizontal segment and at each
side of it in the vertical component.[2,24,35] VFM were applied
at vertical and horizontal components of the wound and both
areas were added without repeating the overlapping zone.
Figure 1 shows the area explored.
EVF: Pressure pain threshold was tested using an EVF device
(Electronic Von Frey Anesthesiometer IITC, Woodland Hills,–USA)[29,36] with a constant slope of increasing pressure up to
the detection of mechanical pain threshold. Threshold was
deﬁned as the lowest pressure that produced pain sensation.
Measurements were performed at 6, 4, and 2cm from the
surgical incision, above and under the wound in the horizontal
segment and at each side of it at the vertical component (Fig. 1).
Each stimulus was applied 3 times and the average from the 6
measurements (3 at each side) for each segment was registered.3– Brush-evoked allodynia was explored using an electrical
toothbrush applied to the skin area as described for VFM.
Anesthesia area was calculated as described for VFM.–QST were applied in the anterior middle third of the left thigh
at all times.2.5. Side effects
Side effects were recorded during the 1st postsurgical week.
Complications such as postoperative nausea/vomiting (PONV),
hemodynamic side effects (new onset arrhythmia or 20%
variation on median arterial pressure compared with the basal
values), cognitive side effects (hallucinations, acute confusional
syndrome, nightmares), visual side effects (diplopia), and
sedation (Ramsay ≥ 2),[37] hospital length of stay and need for
vasoactive drugs or transfusion were registered. They were
considered severe if they required treatment or withdrawal of
analgesic regimen.
Postsurgical complications were registered according to
Dindo-Clavien Classiﬁcation.[38] Analgesia requirement after
discharge was also recorded.2.6. Statistical analysis
This was an observational comparative study between 2 cohorts
with the aim to describe several subjective pain scales and QST
evolution in patients scheduled for major or minor conventional
hepatic resection. Therefore, presence of PPP was not evaluated
using just a single variable but a combination of several ones.
It was decided to recruit all patients who fulﬁlled inclusion
criteria during 18 months. Forty-four patients were included and
it was considered that this sample size would be representative of
the population undergoing hepatic resection in a third-level
hospital like ours. Comparisons between both groups for
variables with a single measurement such as demographical
data, preoperative and intrasurgical variables, side effects, PONV
incidence, hospital length of stay, and vasoactive or transfusion
needs were analyzed by means Mann–Whitney U and data are
reported as median [interquartile range: 25 and 75 percentiles]
and absolute range if they were continuous variables. For
qualitative variables Fisher exact test was applied and data are
reported as absolute and relative frequencies. Inferential analyses
in longitudinal results were conducted using general estimated
equations; these were applied using an unstructured matrix to
Figure 2. Patients ﬂow chart.
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distribution for each dependent variable. These models were
made to include groups, time, and their interaction, and the aim
was to compare time-by-time VAS, analgesia requirement after
discharge, NPSI, PCS, and QST evaluation between groups.
Results of these variables are shown as mean (standard deviation)
or absolute and relative frequencies for each time. Data were
analyzed with statistical analysis software (SPSS version 20; IBM
Corp., Armonk, NY) and the level of signiﬁcance was set at the
2-sided 5% level.3. Results
During the inclusion period, 99 patients underwent elective
hepatic resection in our institution; 44 patients who met the
inclusion criteria were analyzed: 23 in the EPI group and 21 in the
IV group (Fig. 2). All patients completed follow-up (6 months).
In the demographic and prognostic characteristics, the only
signiﬁcant differences found were older age and more frequent
American Society of Anesthesiologists Physical Status Classiﬁca-
tion System (ASA) III–IV class in the IV group (Table 2).Table 2
Patients’ characteristics.
Variables EPI group
Gender: male 14 (60.9%)
Age, y 57 [45; 62]
ASA III–IV 18 (78.3%)
Preoperative pain 1 (4.3%)
Preoperative analgesics intake 1 (4.3%)
Preoperative VAS 0 [0; 0]
Preoperative NPSI 0 [0; 0]
Preoperative PCS 9 [4; 11]
Total wound length, cm 28 [24; 34]
Surgery duration, h 3.33 [2.83; 4]
Major resection 12 (52.2%)
Preoperative EVF in thigh 205 [175; 236]
Preoperative EVF in surgical zone 188 [152; 215]
Data are described as N (%) for qualitative variables and as median [25–75 percentiles] for quantitativ
ASA = American Society of Anesthesiologists Physical Status Classiﬁcation System, EPI = epidural, EV
Catastrophizing Scale, VAS= visual analog scale.
∗
P< .05.
43.1. Subjective scales
Table 3 shows VAS values during the study in the whole sample
and in each separate group. During the 1st postoperative week,
meanVAS values remainedbelow3 and at 1 and6months below1
without differences between groups. In the 1stweek, the number of
patients with VAS > 3 (not controlled pain) was low and similar
between groups. No patient suffered VAS > 3 at 1 or 6 months.
Patients with VAS ≥ 1 at 1 month were 36.4%, and at 6 months
22.7% without signiﬁcant differences between groups.
Means of NPSI and PCS and frequencies of values >0 in the 2
groups and times are shown in Table 4. No signiﬁcant differences
were observed between groups. Total frequency of patients which
still required analgesia at 1 month was 38.6%, and 13.6% at
6 months without signiﬁcant differences between groups.
3.2. QST
At baseline exploration, no patients showed positive responses
with VFM or toothbrush in the thigh or in the expected incision
area. Pain threshold to pressure measured with EVF before
surgery in the thigh or surgical area did not differ between groupsIV group Total sample P
14 (66.70%) 28 (63.6%) .761
67 [59; 74] 61 [53;69] .001
∗
21 (100%) 39 (88.6%) .05
∗
1 (4.8%) 2 (4.5%) 1
1 (4.8%) 2 (4.5%) 1
0 [0; 0] 0 1
0 [0; 0] 0 [0; 0] 1
4 [2; 7] 5 [3; 11] .072
26 [25; 30] 28 [25; 31] .875
3.17 [2.5; 3.75] 3.25 [2.5; 3.83] .391
6 (28.6%) 18 (40.9%) .136
197 [180; 220] 200 [178; 226] .36
159 [146; 194] 175 [146; 211] .155
e variables. EVF data are expressed in grams.
F= electronic Von Frey, IV = intravenous, NPSI=Neuropathic Pain Symptom Inventory, PCS=Pain
Table 3
VAS mean values and patients presenting VAS ≥ 1 and VAS > 3 throughout the study in both groups and in the whole sample.
VAS mean ± 2 SD VAS ≥ 1, N (%) VAS > 3, N (%)
Time EPI group IV group Total P EPI group IV group Total P EPI group IV group Total P
2 h 1.60±1.3 1.95±2.31 1.77±1.84 .54 16 (69.6) 14 (66.7) 30 (68.2) .84 1 (4.3) 2 (9.5) 3 (6.8) .5
24 h 2.43±1.87 2.04±1.59 2.25±1.74 .45 18 (78.3) 16 (76.2) 34 (77.3) .87 6 (26.1) 4 (19) 10 (22.7) .58
7 d 2.39±1.33 2.79±1.67 2.25±1.5 .51 21 (91.3) 15 (71.4) 36 (81.8) .08 6 (26.1) 5 (23.8) 11 (25) .86
1 mo 0.82±1.15 0.66±1.06 0.75±1.1 .63 9 (39.1) 7 (33.3) 16 (36.4) .69 0 (0) 0 (0) 0 (0) NA
6 mo 0.30±0.70 0.33±0.73 0.32±0.71 .89 5 (21.7) 5 (23.8) 10 (22.7) .87 0 (0) 0 (0) 0 (0) NA
Data are described as mean±2 standard deviations for quantitative variables and as N (%) for qualitative variables.
EPI = epidural, IV = intravenous, NA=not applicable, SD= standard deviation, VAS = visual analog scale.
Table 4
Mean values and frequencies of scores >0 of NPSI and PCS throughout the study in both groups.
Mean±2 SD N (%) of results >0
EPI group IV group P EPI group IV group P
NPSI 7 d 7.0435±3.95 8.24±5.72 .41 22 (95.7) 20 (95.2) .95
NPSI 1 mo 6.22±6.98 4.5714±4.49 .34 17 (73.9) 17 (81) .58
NPSI 6 mo 3.09±4.6 1.86±2.83 .27 14 (60.9) 10 (47.6) .37
NPSI 1 mo 8.57±5.91 6.1±7.4 .21 21 (91.3) 16 (76.2) .17
PCS 6 mo 8.22±6.82 5.71±6.81 .21 20 (87) 17 (81) .59
Data are described as mean±2 standard deviations for quantitative variables and as N (%) for qualitative variables.
EPI = epidural, IV = intravenous, NPSI=Neuropathic Pain Symptom Inventory, PCS=Pain Catastrophizing Scale, SD= standard deviation.
Table 5
Means of areas and frequencies of results >0 of allodynia/mechanical hyperalgesia with VFM of 10g at 7 days and 1 month and of
anesthesia areas at 7 days, 1 month, and 6 months.
Mean±2 SD in cm2 N (%) of results >0
EPI group IV group P EPI group IV group P
10 g VFM area 7 d 8±30 19±38 .26 3 (13) 7 (33.3) .10
10 g VFM area 1 mo 6±17 15±29 .2 3 (13) 5 (23.8) .35
Anesthesia area 7 d 26±45 8±18 .08 8 (34.8) 4 (19) .23
Anesthesia area 1 mo 27±40 13±20 .12 11 (47.8) 7 (33.3) .32
Anesthesia area 6 mo 19±30 7±14 .09 10 (43.5) 5 (23.8) .16
Data are described as mean±2 SDs for quantitative variables and as N (%) for qualitative variables.
EPI = epidural, IV = intravenous, SD= standard deviations, VFM=Von Frey Monoﬁlaments.
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time of the study.
Regarding postsurgical allodynia/mechanical hyperalgesia in
the surgical incision area, no patient showed positive responses
with 0.6 or 2gVFMat any timeof the study.With 10gVFM, small
and infrequent areas of allodynia/mechanical hyperalgesia were
foundat7daysand1monthwithout statistical differences between
groups. At 6 months, no patient showed positive responses with
any of the VFM. Regarding anesthesia no statistical signiﬁcant
differences were found between groups (Table 5). Brushed evoked
allodynia was not found in any patient during the study.
Pain thresholds measured with EVF are shown in Table 6.
No signiﬁcant changes were observed between baseline and
postsurgical values at any time. There were no signiﬁcant
differences between groups in the evolution of the horizontal
component of the incision. In the vertical segment of the wound,
pain thresholds were higher in the EPI group compared with the
IV group at all times with signiﬁcant differences at 2cm from the
incision at day 7 and 6 months and at 6cm from the wound in the
1st month.53.3. Side effects and postsurgical complications
Table 7 shows incidence of postsurgical side effects, needs for
analgesia rescue, and length of hospital stay in the whole general
sample and in the 2 separate groups. Twenty-ﬁve percent of
patients did not suffer postsurgical complications according
to Dindo-Clavien criteria; 25% presented type I complications,
34.1% type II, 13.6% type III, and 2.3% type IV without
signiﬁcant differences between groups.
No hemodynamic alterations were detected. No signiﬁcant
differences were observed between groups regarding sedation or
visual alterations. No patient in the EPI group showed cognitive
alterations while in the IV group, 19% (4 patients) presented
cognitive alterations (P = .044). Out of 4, 3 patients in the IV
group who suffered cognitive side effects, presented them
concomitantly with postsurgical complications type II or of
Dindo-Clavien. None of the side effects was considered severe
and withdrawal of analgesic treatment was not needed in any
case.
PONV had a global incidence of 13.6% and need for analgesic
recue with methadone 15.9%, without differences between
Table 6
Pain thresholds with EVF at 6, 4, and 2cm from the surgical wound.
6 cm 4 cm 2 cm
EPI group IV group P EPI group IV group P EPI group IV group P
7 d
Horizontal 176±72 149±54 .16 159±79 153±77 .78 145±65 150±89 .82
Vertical 181±74 152±43 .1 172±69 143±48 .1 167±58 129±45 .01
∗
1 mo
Horizontal 144±40 136±63 .58 131±38 140±62 .57 134±41 139±77 .8
Vertical 158±41 132±39 .03
∗
144±32 124±38 .06 128±32 124±48 .72
6 mo
Horizontal 176±51 157±36 .13 164±54 150±40 .31 158±50 147±40 .38
Vertical 179±51 158±42 .11 169±48 151±37 .14 164±48 144±33 .02
∗
Data are described as mean±2 SDs. EVF data are expressed in grams.
EPI = epidural, EVF= electronic Von Frey, IV = intravenous, SD= standard deviation.
∗
P< .05.
Table 7
Postsurgical complications, side effects incidence, needs for analgesia rescue, and length of hospital stay.
EPI group IV group Total P
Hemodynamic side effects 0 0 0 NA
Sedation 2 (8.7) 1 (4.8) 0.6 1
Cognitive alterations 0 4 (19) 4 (9.1) .04
∗
Visual alterations 1 (4.3) 2 (9.5) 3 (6.8) .6
Postoperative nausea and vomiting 3 (13) 3 (14.3) 6 (13.6) 1
Methadone analgesic rescue 4 (17.4) 3 (14.3) 7 (15.9) 1
Length of hospital stay 10 [8; 16] 10 [8; 14] 10 [8; 15] .89
No Dindo-Clavien complications 6 (26.1) 5 (23.8) 11 (25) .34
Dindo-Clavien complications type I 8 (34.8) 3 (14.3) 11 (25)
Dindo-Clavien complications type II 6 (26.1) 9 (42.9) 15 (34.1)
Dindo-Clavien complications type III 2 (8.7) 4 (19) 6 (13.6)
Dindo-Clavien complications type IV 1 (4.3) 0 1 (2.3)
Vasoactive drugs need 12 (52.2) 6 (28.6) 18 (40.9) .14
Transfusion needs 4 (17.4) 7 (33.3) 11 (25) .30
Data are described as N (%) for qualitative variables and as median [25–75 percentiles] for quantitative variables. EVF data are expressed in grams.
EPI = epidural, EVF= electronic Von Frey, IV = intravenous, NA=not applicable.
∗
P< .05.
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groups. There were no signiﬁcant differences regarding need for
vasoactive drugs or transfusion.4. Discussion
The aim of this study was to determine PPP incidence after 6
months of open hepatectomies, given the absence of prospective
data in the reviewed literature. The studywas designed in order to
evaluate PPP incidence according to clinical manifestations and
neurosensitive changes with 2 different postsurgical analgesic
regimes commonly prescribed in our institution: EPI or IV
analgesia, both containing ketamine.[19] Results showed a global
clinical PPP incidence of 22.7% (considering it as VAS ≥ 1) at
6 months with a median VAS < 0.33 and analgesic requirement
at this time in 13.6% of cases. No patient showed not-controlled
pain (considered as VAS > 3) at 6 months. There were no
differences in PPP incidence assessed neither by VAS nor by NPSI
or PCS between patients with EPI and IV analgesia. Allodynia/
secondary hyperalgesia area assessed by QST was found in few
patients and, when present, it was small sized. Despite the fact
that the study has limitations that will be discussed later, it
provides new information.6Pain after conventional hepatic resection is considered of high
intensity and it is usually treated with potent analgesic techniques
such as EPI. Nevertheless, PPP research after this speciﬁc type of
surgery is limited. Available information about PPP after major
abdominal surgery is in general controversial and PPP following
hepatectomy has not been speciﬁcally addressed.
A retrospective control–case study performed on 101 patients
who underwent different types of abdominal surgeries, which
compared combination of epidural technique and general
anesthesia with general anesthesia alone found a PPP incidence
(measured thorough SF-36 questionnaire[1,39]) at 6 months of
25.7%. In 85 patients who had rectal adenocarcinoma surgery
performed with different analgesia regimes, all of them including
ketamine, a prospective study with telephonic control of VAS
after hospital discharge reported a PPP incidence between 0%
and 48% after a year.[2] On the other hand, in a prospective series
on 20 patients intervened from gastrointestinal or urinary
surgery, PPP (considered as VAS > 0 in movement or rest)
incidence was 30%.[15]
Available data on PPP after hepatic resection surgery are
scarce. There is a retrospective study on 65 liver living donors in
which almost all patients received IV ketamine in antihyper-
algesic doses at the anesthesia induction. It showed a PPP
[1,10,14,44]
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specifying VAS level.[5] There are also 2 studies designed to
evaluate quality of life in which PPP is indirectly evaluated. One
prospective study on 21 liver living donors that describes an
incidence of “wound-related symptoms” of 24% using the SF-36
form[40] and a questionnaire[4] and another on 96 patients who
underwent hepatic resection and who received and returned the
SF-12 formulaire[41] and a VAS by email 3 to 36 months after
surgery. This last one reported a “50% of patients pain-free.”[3]
However, none of these studies speciﬁed VAS level.
Data from published studies make difﬁcult to get clear
information on this topic and to compare our results with
others. Previous studies show disparities regarding analgesic
regimes with or without ketamine, divergence and simplicity in
PPP assessment (only by subjective scales: VAS, SF-36, and SF-12
formulaires and other questionnaires administered by email),
little information about PPP deﬁnition, and lack of long-term
prospective follow-up.
PPP is a chronic kind of pain with neuropathic characteristics
and neurosensorial alterations that range between anesthesia and
allodynia/hyperalgesia. These changes are expressed around the
wound (secondary hyperalgesia area), are related with neuro-
plasticity, and could be related, according to some authors, with
PPP.[2] Assessment of neurosensorial changes before and after
surgical operation should be part of a PPP evaluation together
with subjective scales in order to get information about
neuropathic changes generated after surgery. Nevertheless, the
conventional complete neurosensitive assessment is not applica-
ble to surgical patient or to repeated explorations. An assessment
protocol previously applied by our investigation group[24,29] has
been used in this study. This protocol evaluates patients from
the presurgical time until 6 months after surgery combining
subjective scales with semiobjective assessment through QST.
It includes VAS measuring (deﬁning presence of clinical pain at
6 months as VAS ≥ 1 and uncontrolled pain as VAS > 3), PCS,
NPSI, analgesic requirement after discharge, and secondary
hyperalgesia area exploration through QST in order to detect
changes. Applying this standard PPP exploration procedure,
assessed in a prospective and extensive way and with a longer
follow-up period than other series, our study provides informa-
tion on PPP incidence after hepatectomies not available in the
existing literature. This protocol of PPP assessment is easy to
apply repeatedly in postsurgical patients and permits comparison
of data after surgery with that before it. This makes possible to
follow-up pain characteristics from its beginning until its eventual
chroniﬁcation, allowing to correlate the intensity of acute pain
with QST ﬁndings and PPP development.[5]
Our results suggest that PPP incidence (considering it as VAS ≥
1 in context of other subjective scales and QST results) after
6 months of conventional hepatic resection with usual analgesic
regimes containing ketamine is in the low range, 22.7% and that
information was not reported before.
Available data about the inﬂuence of different postoperative
analgesic techniques in abdominal surgery regarding PPP
incidence are contradictory.[1,2] The advantages of EPI analgesia
after hepatectomy regarding quality of analgesia, hospital length
of stay, and postsurgical complications are not clear and it
is associated with an increase in transfusion and ﬂuids
requirements.[10–12,42,43] In our study, no differences in analgesic
efﬁcacy, PPP, or other perioperative variables were found in
patients receiving IV or EPI analgesia regimens, both containing
ketamine. Therefore, the EPI route does not seem to offer
advantages in these patients who also have frequent contra-7indications for EPI catheter insertion. The only
difference between both analgesic techniques used was a higher
incidence of cognitive alterations in the IV group. According to
one previous study which used the same doses of ketamine and
published by our group,[31] plasmatic levels of ketamine were
similar with IV or EPI administration, therefore we attribute
cognitive alterations found in IV group to the older age and more
frequent comorbidities of the patients. The fact that the election
of EPI or IV analgesic technique relied upon the single treating
anesthesiologist could have biased the distribution of patients. In
older patients with more comorbidities, IV analgesia would have
been considered safer than the EPI technique. This is a study
limitation because it does not allow to compare PPP incidence
between groups. However, this does not invalidate the low global
incidence of PPP and secondary hyperalgesia after conventional
hepatic resection surgery found in this study.
The importance of secondary hyperalgesia area in PPP
prediction and its possible reduction with ketamine is a topic
of great interest because it would allow an early detection of
patients that couldmore probably develop PPP and to act upon it.
Although the secondary hyperalgesia area that we have found in
our study was small and in few patients, we cannot discard that
ketamine could have had an inﬂuence in the low incidence of PPP.
Up to now, it has not been reliably proved that ketamine reduces
PPP incidence, despite the fact that it diminishes the opioid
requirements in postoperative period[20,23] and the size of
secondary hyperalgesia area.[2] In the literature, doses and routes
of administration of ketamine as antihyperalgesic in the
perioperative period are very variable and generally given during
less time than in our study, in which all patients received it, either
IV or EPI, during surgery and for the ﬁrst 5 postsurgical days. The
doses administered in the present study have demonstrated
to achieve plasmatic levels within the recommended antihyper-
algesic range.[24]
The exploration of the secondary hyperalgesia area with QST
has been made in different surgical incisions, but not after
hepatectomies.[2] Conventional hepatic resection wound is
different to lineal incisions like those made for thoracotomies
or other laparotomies[2,31] because it has an “L” shape with a
vertical and a horizontal components. The hyperalgesia area that
has to be evaluated should include the 2 components, which
coincide in the angle zone, and although we have not found
references to this type of calculation, it is considered the best way
to do it (Fig. 1).
Among the QST applied in our study, we considered that small
size VFM would explore mechanical allodynia (Ab ﬁbers). The
thicker VFM of 10g in this case could reach to explore Ad and
C ﬁbers that would correspond to mechanical hyperalgesia,
although this threshold has not been clearly established. The only
response suggestive of secondary hyperalgesia found, was with
10g VFM, but it was discrete and infrequent. We cannot discard
that if we had applied thicker VFM or a “pin prick” test, more
marked changes would have been detected. This simpliﬁed QST
exploration protocol used could have been a study limitation and
after discussing this point we have included in our protocol
thicker VFM as well as temperature exploration which would
give information about changes in Ad and C ﬁbers and would not
complicate the exploration too much.
Regarding pain threshold with EFV, changes found through-
out the study have been also very discrete; however, an interesting
ﬁnding was that the vertical component, but not the horizontal
one showed differences between groups. In the EPI group, EFV
threshold was higher compared with the IV one. In spite of this,
residual pain after major abdominal surgery. Acta Anaesthesiol Belg
Masgoret et al. Medicine (2017) 96:15 Medicinewe have not found data in the literature about QST in complex
wounds like that of hepatectomy. We speculate that perhaps
because the vertical component of the incision injures more
nerves with the corresponding increase in the neuropathic
component,[45,46] the EPI block containing ketamine could be
more effective to prevent secondary hyperalgesia. These differ-
ences were not evident with any of the subjective scales.
The lack of correlation between QST and subjective pain
expression is frequently found in the literature,[24,33,34,47] which
has made that some authors doubt about the relationship
between the hyperalgesia area and PPP.[39,45] When this study
was designed, we expected both PPP and QST changes to be
higher, but their low incidence did not allow us to assess their
relationship. The small size of the sample is a limitation of this
study. Nevertheless, even though our hospital is a reference center
for hepatic and transplantation surgery, to recruit our sample
took a long time.
In PPP development, the concept of “diffuse noxious inhibitory
control” (DNIC) is gaining more importance.[8] For this reason,
we included in our protocol the assessment of a distant area from
the wound as the thigh. Although we did not ﬁnd any changes in
this area, we believe that it is worth considering because it is a
very simple exploration that allows discarding central inﬂuences.
In conclusion, PPP incidence after open hepatectomies with EPI
or IV analgesia containing ketamine was 22% at 6 months after
surgery. Secondary hyperalgesia responses were infrequent and
small sized. Immediate clinical application of our results is that
EPI analgesia does not offer advantages in front of IV analgesia in
these particular patients with potential coagulation alterations.
On the other hand, it seems advisable to include ketamine in the
analgesic regimes, considering the low incidence of adverse effects
and PPP found in this study. Regarding research in PPP, the
various responses to the QST found in the vertical component of
the incisions demonstrate the importance of establishing
exploration protocols in different types of wounds.Acknowledgments
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